Results 241 to 250 of about 11,620,757 (255)

Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross

Transfusion and Apheresis Science, 2021
Marcia Cardoso, Nicolas Malvaux, Anne Schuhmacher   +2 more
exaly  

Effect of mirasol pathogen reduction technology system on immunomodulatory molecules of apheresis platelets

Transfusion and Apheresis Science, 2023
Marianna Politou, Abraham Pouliakis, Serena Valsami   +2 more
exaly  

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products

Vox Sanguinis, 2004
Dirk de Korte, Raymond P Goodrich
exaly  

Progress towards an appropriate pathogen reduction technology for whole blood in Africa

ISBT Science Series, 2020
Claude T Tagny, Marion C Lanteri, Soraya Amar El Dusouqui   +2 more
exaly  

Update on pathogen reduction technology

ISBT Science Series, 2013
Brian Custer
exaly  

Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets

Transfusion and Apheresis Science, 2013
Çiğdem Akalın Akkök
exaly  

Risks, benefits and the role of stakeholders in pathogen reduction technology

Health, Risk and Society, 2014
Bruce Newbold, John Eyles, Nancy M Heddle   +2 more
exaly  

The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover

Vox Sanguinis, 2011
Denese C Marks, Raymond P Goodrich, Lacey Johnson   +2 more
exaly  

Pathogen reduction technology (Mirasol®) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS

Vox Sanguinis, 2009
Raymond P Goodrich, H Klüter
exaly  

Practical issues that should be considered when planning the implementation of pathogen reduction technology for plateletpheresis

Transfusion and Apheresis Science, 2015
Teresa Jimenez-Marco, Enrique Girona-Llobera   +1 more
exaly